サマリー

鼻腔スプレーの世界市場は、2023年から2030年の予測期間に6.7%のCAGRを記録すると予測されます。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年で、予測期間は2023年から2030年です。

市場セグメンテーション

鼻腔スプレーの世界市場：製品タイプ別（充血除去鼻腔スプレー、ステロイド鼻腔スプレー、塩水/生理食塩水鼻腔スプレー、その他）、容器デザイン別（ポンプボトル、加圧キャニスター）、剤形別（多剤式、単位/単剤式、二剤式）、治療クラス別（抗ヒスタミン薬、鼻腔ステロイド、マスト細胞阻害剤、抗コリン剤）、用途（鼻づまり、アレルギー性・非アレルギー性鼻炎、中枢神経系障害、ワクチン接種、その他）、処方・入手方法（Over The Counter、処方薬）、エンドユーザー（在宅医療、病院、診療所、地域医療）、国（U．S.,カナダ、メキシコ、ドイツ、英国、フランス、イタリア、スペイン、スイス、オランダ、ベルギー、ロシア、トルコ、欧州のその他、中国、日本、インド、オーストラリア、韓国、マレーシア、タイ、シンガポール、インドネシア、フィリピン、アジア太平洋のその他、ブラジル、アルゼンチン、南米のその他、南アフリカ、サウジアラビア、UAE、中東・アフリカのその他）産業動向と2030年までの予測

鼻腔スプレーの世界市場の成長に寄与する主な要因としては、以下のものが挙げられます：

- 鼻腔スプレーの治療用途の増加
- アレルギー疾患やCOVID-19などのパンデミックに対応した点鼻薬の需要増
市場関係者
世界の点鼻薬市場で活動している主な市場参入企業は以下の通りです：

- エマージェンシー
- Cipla Inc.
- サンド・インターナショナルGmbH（ノバルティス社傘下）
- アイトゥヘルス（アイトゥバイオファーマ社の子会社）
- バイエル社
- グラクソ・スミスクライン plc.
- アサーティオ・セラピューティクス・インク
- アウレナ・ラボラトリーズ
- ジェイ・ファーマシューティカルズ
- セント・ルナトゥス
- ウルトラテック インディア リミテッド
- キャタレント社（Catalent, Inc.
- Teva Pharmaceuticals USA, Inc. (Teva Pharmaceutical Industries Ltd.の子会社)
- ファイザー株式会社（Pfizer Inc.
- ヴィアトリス・インク
- リーフォード・ヘルスケアLtd
- アイシワリヤグループ

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 OVERVIEW 23
1.4 LIMITATIONS 25
1.5 MARKETS COVERED 25
2 MARKET SEGMENTATION 27
2.1 MARKETS COVERED 27
2.2 GEOGRAPHICAL SCOPE 28
2.3 YEARS CONSIDERED FOR THE STUDY 29
2.4 CURRENCY AND PRICING 29
2.5 DBMR TRIPOD DATA VALIDATION MODEL 30
2.6 MULTIVARIATE MODELLING 33
2.7 PRODUCT TYPE LIFELINE CURVE 33
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34
2.9 DBMR MARKET POSITION GRID 35
2.10 MARKET END USER COVERAGE GRID 36
2.11 VENDOR SHARE ANALYSIS 37
2.12 SECONDARY SOURCES 38
2.13 ASSUMPTIONS 38
3 EXECUTIVE SUMMARY 39
4 PREMIUM INSIGHTS 42
4.1 PORTER’S FIVE FORCES MODEL 45
4.2 PESTEL ANALYSIS 46
5 INDUSTRY INSIGHTS: GLOBAL NASAL SPRAY MARKET 47
5.1 INDUSTRY INSIGHTS 47
6 REGULATIONS: GLOBAL NASAL SPRAY MARKET 48
6.1 REGULATORY SCENARIO IN THE U.S. 48
6.2 REGULATORY SCENARIO IN EUROPE 49
6.3 REGULATORY SCENARIO IN INDIA 50
6.4 REGULATORY SCENARIO IN CHINA 50
7 MARKET OVERVIEW 51
7.1 DRIVERS 53
7.1.1 INCREASE IN INFECTION AND ALLERGIC CASES 53
7.1.2 RISING PREVALENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA 53
7.1.3 EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY 54
7.1.4 IMPROVING PATIENT COMPLIANCE AND ACCEPTABILITY 55
7.2 RESTRAINTS 56
7.2.1 PRODUCT RECALLS 56
7.2.2 ADVERSE EFFECTS OF USING NASAL SPRAYS 57
7.3 OPPORTUNITIES 58
7.3.1 NEW RISING DEMAND FOR SELF-ADMINISTRATIVE DRUG DELIVERY 58
7.3.2 EXPANDING THERAPEUTIC APPLICATIONS FOR NASAL SPRAYS 58
7.3.3 STRATEGIC INITIATIVES TAKEN BY KEY MARKET PLAYERS 59
7.4 CHALLENGES 59
7.4.1 REGULATORY HURDLES 59
7.4.2 ADDICTION TO NASAL SPRAY 60
8 GLOBAL NASAL SPRAY MARKET, BY PRODUCT TYPE 61
8.1 OVERVIEW 62
8.2 DECONGESTION NASAL SPRAY 65
8.3 STEROID NASAL SPRAY 66
8.4 SALT WATER SOLUTION/SALINE NASAL SPRAY 67
8.5 OTHERS 68
9 GLOBAL NASAL SPRAY MARKET, BY CONTAINER DESIGN 69
9.1 OVERVIEW 70
9.2 PUMP BOTTLES 73
9.3 PRESSURIZED CANISTERS 74
10 GLOBAL NASAL SPRAY MARKET, BY DOSAGE FORM 75
10.1 OVERVIEW 76
10.2 MULTI DOSE 79
10.3 UNIT/SINGLE DOSE 80
10.4 BI DOSE 81
11 GLOBAL NASAL SPRAY MARKET, BY THERAPEUTIC CLASS 83
11.1 OVERVIEW 84
11.2 ANTIHISTAMINE 87
11.3 NASAL STEROIDS 88
11.4 MAST CELL INHIBITOR 89
11.5 ANTICHOLINERGIC 90
12 GLOBAL NASAL SPRAY MARKET, BY APPLICATION 91
12.1 OVERVIEW 92
12.2 NASAL CONGESTION 95
12.3 ALLERGIC AND NON-ALLERGIC RHINITIS 96
12.4 CENTRAL NERVOUS SYSTEM DISORDERS 97
12.5 VACCINATION 98
12.6 OTHERS 99
13 GLOBAL NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY 100
13.1 OVERVIEW 101
13.2 PRESCRIBED 104
13.3 OVER THE COUNTER 105
14 GLOBAL NASAL SPRAY MARKET, BY END USER 107
14.1 OVERVIEW 108
14.2 HOME CARE SETTINGS 111
14.3 HOSPITALS 112
14.4 CLINICS 113
14.5 COMMUNITY HEALTH CARE 114
15 GLOBAL NASAL SPRAY MARKET, BY REGION 115
15.1 OVERVIEW 116
15.2 NORTH AMERICA 122
15.2.1 U.S. 129
15.2.2 CANADA 131
15.2.3 MEXICO 133
15.3 EUROPE 135
15.3.1 GERMANY 143
15.3.2 U.K. 145
15.3.3 FRANCE 147
15.3.4 ITALY 149
15.3.5 SPAIN 151
15.3.6 SWITZERLAND 153
15.3.7 NETHERLANDS 155
15.3.8 BELGIUM 157
15.3.9 RUSSIA 159
15.3.10 TURKEY 161
15.3.11 REST OF EUROPE 163
15.4 ASIA-PACIFIC 164
15.4.1 CHINA 172
15.4.2 JAPAN 174
15.4.3 INDIA 176
15.4.4 AUSTRALIA 178
15.4.5 SOUTH KOREA 180
15.4.6 MALAYSIA 182
15.4.7 THAILAND 184
15.4.8 SINGAPORE 186
15.4.9 INDONESIA 188
15.4.10 PHILIPPINES 190
15.4.11 REST OF ASIA-PACIFIC 192
15.5 SOUTH AMERICA 193
15.5.1 BRAZIL 200
15.5.2 ARGENTINA 202
15.5.3 REST OF SOUTH AMERICA 204
15.6 MIDDLE EAST AND AFRICA 205
15.6.1 SOUTH AFRICA 212
15.6.2 UAE 214
15.6.3 SAUDI ARABIA 216
15.6.4 REST OF MIDDLE EAST & AFRICA 218
16 GLOBAL NASAL SPRAY MARKET, COMPANY LANDSCAPE 219
16.1 COMPANY SHARE ANALYSIS: GLOBAL 219
16.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 220
16.3 COMPANY SHARE ANALYSIS: EUROPE 221
16.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 222
17 SWOT ANALYSIS 223
18 COMPANY PROFILE 224
18.1 GLAXOSMITHKLINE PLC. 224
18.1.1 COMPANY SNAPSHOT 224
18.1.2 REVENUE ANALYSIS 224
18.1.3 COMPANY SHARE ANALYSIS 225
18.1.4 PRODUCT PORTFOLIO 225
18.1.5 RECENT DEVELOPMENTS 225
18.2 PFIZER INC. 227
18.2.1 COMPANY SNAPSHOT 227
18.2.2 REVENUE ANALYSIS 227
18.2.3 COMPANY SHARE ANALYSIS 228
18.2.4 PRODUCT PORTFOLIO 228
18.2.5 RECENT DEVELOPMENTS 228
18.3 EMERGENT 230
18.3.1 COMPANY SNAPSHOT 230
18.3.2 REVENUE ANALYSIS 230
18.3.3 COMPANY SHARE ANALYSIS 231
18.3.4 PRODUCT PORTFOLIO 231
18.3.5 RECENT DEVELOPMENT 231
18.4 SANDOZ INTERNATIONAL GMBH (A PART OF NOVARTIS) 232
18.4.1 COMPANY SNAPSHOT 232
18.4.2 REVENUE ANALYSIS 232
18.4.3 COMPANY SHARE ANALYSIS 233
18.4.4 PRODUCT PORTFOLIO 233
18.4.5 RECENT DEVELOPMENT 233
18.5 CATALENT, INC. 234
18.5.1 COMPANY SNAPSHOT 234
18.5.2 REVENUE ANALYSIS 234
18.5.3 COMPANY SHARE ANALYSIS 235
18.5.4 PRODUCT PORTFOLIO 235
18.5.5 RECENT DEVELOPMENTS 235
18.6 AYTU HEALTH (A SUBSIDIARY OF AYTU BIOPHARMA, INC.) 237
18.6.1 COMPANY SNAPSHOT 237
18.6.2 REVENUE ANALYSIS 237
18.6.3 PRODUCT PORTFOLIO 238
18.6.4 RECENT DEVELOPMENTS 238
18.7 AISHWARYA GROUP 239
18.7.1 COMPANY SNAPSHOT 239
18.7.2 PRODUCT PORTFOLIO 239
18.7.3 RECENT DEVELOPMENTS 239
18.8 ASSERTIO THERAPEUTICS, INC. 240
18.8.1 COMPANY SNAPSHOT 240
18.8.2 REVENUE ANALYSIS 240
18.8.3 PRODUCT PORTFOLIO 241
18.8.4 RECENT DEVELOPMENT 241
18.9 AURENA LABORATORIES. 242
18.9.1 COMPANY SNAPSHOT 242
18.9.2 PRODUCT PORTFOLIO 242
18.9.3 RECENT DEVELOPMENTS 242
18.10 BAYER AG 244
18.10.1 COMPANY SNAPSHOT 244
18.10.2 REVENUE ANALYSIS 244
18.10.3 COMPANY SHARE ANALYSIS 245
18.10.4 PRODUCT PORTFOLIO 245
18.10.5 RECENT DEVELOPMENTS 245
18.11 CIPLA INC. 247
18.11.1 COMPANY SNAPSHOT 247
18.11.2 REVENUE ANALYSIS 247
18.11.3 PRODUCT PORTFOLIO 248
18.11.4 RECENT DEVELOPMENT 248
18.12 J PHARMACEUTICALS. 249
18.12.1 COMPANY SNAPSHOT 249
18.12.2 PRODUCT PORTFOLIO 249
18.12.3 RECENT DEVELOPMENTS 249
18.13 LEEFORD HEALTHCARE LTD 250
18.13.1 COMPANY SNAPSHOT 250
18.13.2 PRODUCT PORTFOLIO 250
18.13.3 RECENT DEVELOPMENTS 250
18.14 ST. RENATUS. 251
18.14.1 COMPANY SNAPSHOT 251
18.14.2 PRODUCT PORTFOLIO 251
18.14.3 RECENT DEVELOPMENTS 251
18.15 TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD) 252
18.15.1 COMPANY SNAPSHOT 252
18.15.2 REVENUE ANALYSIS 252
18.15.3 PRODUCT PORTFOLIO 253
18.15.4 RECENT DEVELOPMENTS 253
18.16 ULTRATECH INDIA LIMITED 254
18.16.1 COMPANY SNAPSHOT 254
18.16.2 PRODUCT PORTFOLIO 254
18.16.3 RECENT DEVELOPMENTS 254
18.17 VIATRIS INC. 255
18.17.1 COMPANY SNAPSHOT 255
18.17.2 REVENUE ANALYSIS 255
18.17.3 COMPANY SHARE ANALYSIS 256
18.17.4 PRODUCT PORTFOLIO 256
18.17.5 RECENT DEVELOPMENT 256
19 QUESTIONNAIRE 257
20 RELATED REPORTS 261

ページTOPに戻る

図表リスト

LIST OF TABLES
TABLE 1 GLOBAL NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 64
TABLE 2 GLOBAL DECONGESTION NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 66
TABLE 3 GLOBAL STEROID NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 67
TABLE 4 GLOBAL SALT WATER SOLUTION/SALINE NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 68
TABLE 5 GLOBAL OTHERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 68
TABLE 6 GLOBAL NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 72
TABLE 7 GLOBAL PUMP BOTTLES IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 73
TABLE 8 GLOBAL PRESSURIZED CANISTERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 74
TABLE 9 GLOBAL NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 78
TABLE 10 GLOBAL MULTI DOSE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 79
TABLE 11 GLOBAL UNIT/SINGLE DOSE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 81
TABLE 12 GLOBAL BI DOSE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 82
TABLE 13 GLOBAL NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 86
TABLE 14 GLOBAL ANTIHISTAMINE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 87
TABLE 15 GLOBAL NASAL STEROIDS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 88
TABLE 16 GLOBAL MAST CELL INHIBITOR IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 89
TABLE 17 GLOBAL ANTICHOLINERGIC IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 90
TABLE 18 GLOBAL NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 94
TABLE 19 GLOBAL NASAL CONGESTION IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 20 GLOBAL ALLERGIC AND NON-ALLERGIC RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 96
TABLE 21 GLOBAL CENTRAL NERVOUS SYSTEM DISORDERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 22 GLOBAL VACCINATION IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 98
TABLE 23 GLOBAL OTHERS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 99
TABLE 24 GLOBAL NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 103
TABLE 25 GLOBAL PRESCRIBED IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 104
TABLE 26 GLOBAL OVER THE COUNTER IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 106
TABLE 27 GLOBAL NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 110
TABLE 28 GLOBAL HOME CARE SETTINGS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 111
TABLE 29 GLOBAL HOSPITALS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 112
TABLE 30 GLOBAL CLINICS IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 113
TABLE 31 GLOBAL COMMUNITY HEALTH CARE IN NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 114
TABLE 32 GLOBAL NASAL SPRAY MARKET, BY REGION, 2021-2030 (USD MILLION) 121
TABLE 33 NORTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 127
TABLE 34 NORTH AMERICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 35 NORTH AMERICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 127
TABLE 36 NORTH AMERICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 127
TABLE 37 NORTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 128
TABLE 38 NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 128
TABLE 39 NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 128
TABLE 40 NORTH AMERICA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 128
TABLE 41 U.S. NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
TABLE 42 U.S. NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 129
TABLE 43 U.S. NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 129
TABLE 44 U.S. NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 129
TABLE 45 U.S. NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 130
TABLE 46 U.S. NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 130
TABLE 47 U.S. NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 130
TABLE 48 CANADA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 49 CANADA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 131
TABLE 50 CANADA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 131
TABLE 51 CANADA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 131
TABLE 52 CANADA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 132
TABLE 53 CANADA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 132
TABLE 54 CANADA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 132
TABLE 55 MEXICO NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
TABLE 56 MEXICO NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 133
TABLE 57 MEXICO NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 133
TABLE 58 MEXICO NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 133
TABLE 59 MEXICO NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 134
TABLE 60 MEXICO NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 134
TABLE 61 MEXICO NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 134
TABLE 62 EUROPE NASAL SPRAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 140
TABLE 63 EUROPE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
TABLE 64 EUROPE NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 140
TABLE 65 EUROPE NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 141
TABLE 66 EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 141
TABLE 67 EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 141
TABLE 68 EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 141
TABLE 69 EUROPE NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 142
TABLE 70 GERMANY NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
TABLE 71 GERMANY NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 143
TABLE 72 GERMANY NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 143
TABLE 73 GERMANY NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 143
TABLE 74 GERMANY NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 144
TABLE 75 GERMANY NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 144
TABLE 76 GERMANY NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 144
TABLE 77 U.K. NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 78 U.K. NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 145
TABLE 79 U.K. NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 145
TABLE 80 U.K. NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 145
TABLE 81 U.K. NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 146
TABLE 82 U.K. NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 146
TABLE 83 U.K. NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 146
TABLE 84 FRANCE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
TABLE 85 FRANCE NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 147
TABLE 86 FRANCE NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 147
TABLE 87 FRANCE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 147
TABLE 88 FRANCE NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 148
TABLE 89 FRANCE NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 148
TABLE 90 FRANCE NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 148
TABLE 91 ITALY NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
TABLE 92 ITALY NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 149
TABLE 93 ITALY NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 149
TABLE 94 ITALY NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 149
TABLE 95 ITALY NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 150
TABLE 96 ITALY NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 150
TABLE 97 ITALY NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 150
TABLE 98 SPAIN NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
TABLE 99 SPAIN NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 151
TABLE 100 SPAIN NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 151
TABLE 101 SPAIN NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 151
TABLE 102 SPAIN NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 152
TABLE 103 SPAIN NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 152
TABLE 104 SPAIN NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 152
TABLE 105 SWITZERLAND NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
TABLE 106 SWITZERLAND NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 153
TABLE 107 SWITZERLAND NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 153
TABLE 108 SWITZERLAND NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 153
TABLE 109 SWITZERLAND NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 154
TABLE 110 SWITZERLAND NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 154
TABLE 111 SWITZERLAND NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 154
TABLE 112 NETHERLANDS NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 113 NETHERLANDS NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 155
TABLE 114 NETHERLANDS NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 155
TABLE 115 NETHERLANDS NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 155
TABLE 116 NETHERLANDS NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 156
TABLE 117 NETHERLANDS NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 156
TABLE 118 NETHERLANDS NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 156
TABLE 119 BELGIUM NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 157
TABLE 120 BELGIUM NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 157
TABLE 121 BELGIUM NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 157
TABLE 122 BELGIUM NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 157
TABLE 123 BELGIUM NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 158
TABLE 124 BELGIUM NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 158
TABLE 125 BELGIUM NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 158
TABLE 126 RUSSIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
TABLE 127 RUSSIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 159
TABLE 128 RUSSIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 159
TABLE 129 RUSSIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 159
TABLE 130 RUSSIA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 160
TABLE 131 RUSSIA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 160
TABLE 132 RUSSIA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 160
TABLE 133 TURKEY NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
TABLE 134 TURKEY NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 161
TABLE 135 TURKEY NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 161
TABLE 136 TURKEY NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 161
TABLE 137 TURKEY NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 162
TABLE 138 TURKEY NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 162
TABLE 139 TURKEY NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 162
TABLE 140 REST OF EUROPE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
TABLE 141 ASIA-PACIFIC NASAL SPRAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 169
TABLE 142 ASIA-PACIFIC NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
TABLE 143 ASIA-PACIFIC NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 169
TABLE 144 ASIA-PACIFIC NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 170
TABLE 145 ASIA-PACIFIC NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 170
TABLE 146 ASIA-PACIFIC NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 170
TABLE 147 ASIA-PACIFIC NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 170
TABLE 148 ASIA-PACIFIC NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 171
TABLE 149 CHINA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 172
TABLE 150 CHINA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 172
TABLE 151 CHINA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 172
TABLE 152 CHINA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 172
TABLE 153 CHINA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 173
TABLE 154 CHINA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 173
TABLE 155 CHINA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 173
TABLE 156 JAPAN NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
TABLE 157 JAPAN NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 174
TABLE 158 JAPAN NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 174
TABLE 159 JAPAN NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 174
TABLE 160 JAPAN NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 175
TABLE 161 JAPAN NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 175
TABLE 162 JAPAN NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 175
TABLE 163 INDIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 176
TABLE 164 INDIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 176
TABLE 165 INDIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 176
TABLE 166 INDIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 176
TABLE 167 INDIA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 177
TABLE 168 INDIA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 177
TABLE 169 INDIA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 177
TABLE 170 AUSTRALIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 178
TABLE 171 AUSTRALIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 178
TABLE 172 AUSTRALIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 178
TABLE 173 AUSTRALIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 178
TABLE 174 AUSTRALIA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 179
TABLE 175 AUSTRALIA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 179
TABLE 176 AUSTRALIA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 179
TABLE 177 SOUTH KOREA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
TABLE 178 SOUTH KOREA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 180
TABLE 179 SOUTH KOREA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 180
TABLE 180 SOUTH KOREA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 180
TABLE 181 SOUTH KOREA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 181
TABLE 182 SOUTH KOREA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 181
TABLE 183 SOUTH KOREA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 181
TABLE 184 MALAYSIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 182
TABLE 185 MALAYSIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 182
TABLE 186 MALAYSIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 182
TABLE 187 MALAYSIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 182
TABLE 188 MALAYSIA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 183
TABLE 189 MALAYSIA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 183
TABLE 190 MALAYSIA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 183
TABLE 191 THAILAND NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 184
TABLE 192 THAILAND NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 184
TABLE 193 THAILAND NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 184
TABLE 194 THAILAND NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 184
TABLE 195 THAILAND NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 185
TABLE 196 THAILAND NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 185
TABLE 197 THAILAND NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 185
TABLE 198 SINGAPORE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 186
TABLE 199 SINGAPORE NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 186
TABLE 200 SINGAPORE NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 186
TABLE 201 SINGAPORE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 186
TABLE 202 SINGAPORE NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 187
TABLE 203 SINGAPORE NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 187
TABLE 204 SINGAPORE NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 187
TABLE 205 INDONESIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 188
TABLE 206 INDONESIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 188
TABLE 207 INDONESIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 188
TABLE 208 INDONESIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 188
TABLE 209 INDONESIA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 189
TABLE 210 INDONESIA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 189
TABLE 211 INDONESIA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 189
TABLE 212 PHILIPPINES NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 190
TABLE 213 PHILIPPINES NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 190
TABLE 214 PHILIPPINES NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 190
TABLE 215 PHILIPPINES NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 190
TABLE 216 PHILIPPINES NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 191
TABLE 217 PHILIPPINES NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 191
TABLE 218 PHILIPPINES NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 191
TABLE 219 REST OF ASIA-PACIFIC NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 192
TABLE 220 SOUTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 198
TABLE 221 SOUTH AMERICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 198
TABLE 222 SOUTH AMERICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 198
TABLE 223 SOUTH AMERICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 198
TABLE 224 SOUTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 199
TABLE 225 SOUTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 199
TABLE 226 SOUTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 199
TABLE 227 SOUTH AMERICA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 199
TABLE 228 BRAZIL NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 200
TABLE 229 BRAZIL NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 200
TABLE 230 BRAZIL NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 200
TABLE 231 BRAZIL NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 200
TABLE 232 BRAZIL NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 201
TABLE 233 BRAZIL NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 201
TABLE 234 BRAZIL NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 201
TABLE 235 ARGENTINA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 202
TABLE 236 ARGENTINA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 202
TABLE 237 ARGENTINA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 202
TABLE 238 ARGENTINA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 202
TABLE 239 ARGENTINA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 203
TABLE 240 ARGENTINA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 203
TABLE 241 ARGENTINA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 203
TABLE 242 REST OF SOUTH AMERICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 204
TABLE 243 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 210
TABLE 244 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 210
TABLE 245 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2021-2030 (USD MILLION) 210
TABLE 246 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2021-2030 (USD MILLION) 210
TABLE 247 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2021-2030 (USD MILLION) 211
TABLE 248 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 211
TABLE 249 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY, 2021-2030 (USD MILLION) 211
TABLE 250 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY END USER, 2021-2030 (USD MILLION) 211